We use cookies for a better user experience. Read our Privacy Policy

I Agree

Nanoparticle Contract Manufacturing Market

Nanoparticle Contract Manufacturing Market (Type of Nanoparticle: Polymer Nanoparticle, Lipid Nanoparticle, Nanocrystal, and Inorganic Nanoparticle) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Nanoparticle Contract Manufacturing Market Outlook 2031

  • The global nanoparticle contract manufacturing market was valued at US$ 86.5 Bn in 2021
  • The global market is projected to grow at a CAGR of 7.6% from 2022 to 2031
  • The global nanoparticle contract manufacturing market is anticipated to reach more than US$ 176.5 Bn by the end of 2031

Analysts’ Viewpoint on Nanoparticle Contract Manufacturing Market Scenario

Increase in adoption of nanomedicines is driving the global nanoparticle contract manufacturing market. Nanoparticles are used for the treatment of various conditions including infectious diseases, cancers, and nervous system disorders. Currently, more than 50 nanoparticle products are available in the market. Rise in issues related to drug solubility and bioavailability are expected to fuel the market. Majority of pharmaceutical companies face drug solubility issues during the production of new drugs. Adoption of nanoparticles helps minimize drug solubility and bioavailability issues. Several pharmaceutical companies are outsourcing the production of nanoparticle products. Key nanoparticle contract manufacturers are expanding their production capabilities to cater to the increase in demand for new nanoparticle products.

Nanoparticle Contract Manufacturing Market

Global Nanoparticle Contract Manufacturing Market Introduction

Nanoparticles are used in the formation of nanomedicines. The nanosize of particles, in the range of 1 to 100 nanometers, helps enhance the physiological properties of drugs. There are four types of nanoparticles: nanocrystals, polymeric nanoparticles, lipid nanoparticles, and inorganic nanoparticles. Liposomes and lipid nanoparticles are similar in design. Lipid nanoparticles are used as colloidal carriers for bioactive organic molecules in cancer treatment.

Polymer-based nanoparticles include dendrimers, micelles, drug conjugates, and protein nanoparticles. Inorganic nanoparticles include metal nanoparticles manufactured from gold and silver. Nanoparticle products are also employed in medical imaging and diagnosis. Gold nanoparticles are gaining traction in the healthcare sector due to their ability to detect microbial cells, metabolites, and tumor cells.

Request a sample to get extensive insights into the Nanoparticle Contract Manufacturing Market

Increase in Preference for Contract Manufacturing Augmenting Global Nanoparticle Contract Manufacturing Market Size

Pharmaceutical companies are increasingly preferring contract manufacturing, especially for the production of nanoparticles. Around 60% of nanoparticle products are manufactured through contract manufacturing. Contracting a supplier for medical-grade nanoparticles enables sponsors to leverage new technologies (available with the service provider), access larger capacities, and achieve greater operational flexibility. This helps reduce expenses incurred on resources and time required for production, thus subsequently lowering the cost of final products.

Rise in Prevalence of Cancer and Other Chronic Diseases Driving Global Nanoparticle Contract Manufacturing Market

The burden of chronic diseases across the globe is expected to rise significantly in the next few years. According to the American Cancer Society, the U.S. recorded around 1.9 million new cancer cases and 608,570 cancer deaths in 2021. Nanoparticle products are primarily used for the treatment of cancer. Currently, more than 40% of nanoparticle products are under phase II development. COVID-19 has adversely impacted the overall contract manufacturing market. The pandemic led to a significant decline in the production of nanoparticles.

Request a custom report on Nanoparticle Contract Manufacturing Market

R&D of New Products Fueling Lipid Nanoparticle Segment

Based on type of nanoparticle, the global nanoparticle contract manufacturing market has been segmented into polymer nanoparticle, lipid nanoparticle, nanocrystal, and inorganic nanoparticle. The lipid nanoparticle segment accounted for significant share of the global market in 2021. Lipid nanoparticles include liposomes, solid-lipid nanoparticles, and exosomes. Currently, more than 20 lipid nanoparticles are available in the market.

Increase in R&D of lipid nanoparticle products is likely to drive the lipid nanoparticle segment during the forecast period. Currently, more than 30 liposome products are in the pipeline; most of these have potential in the treatment of cancer. Lipid nanoparticles provide several advantages such as protection to the DNA from degradative processes and increase in solubility and bioavailability of products.

Growth in Incidence of Chronic Diseases Bolstering Therapeutics Segment

In terms of application, the global nanoparticle contract manufacturing market has been classified into therapeutics, regenerative medicines, diagnostics, vaccines, and others. The therapeutics segment held major share of the market in 2021. Nanoparticle products aid in the treatment of cancer, neurological disorders, and genetic diseases. Thus, increase in incidence of chronic diseases is boosting the therapeutics segment.

Increase in Pharmaceutical Contract Manufacturing Propelling Pharmaceutical Companies Segment

Based on end-user, the global nanoparticle contract manufacturing market has been bifurcated into pharmaceutical companies and biotechnology companies. The pharmaceutical companies segment is anticipated to account for major share of the global nanoparticle contract manufacturing market during the forecast period. Growth of the segment can be ascribed to factors such as rise in preference for contract manufacturing and increase in number of contract manufacturers engaged in development of nanoparticle products.

Regional Outlook of Global Nanoparticle Contract Manufacturing Market

According to a recent analysis of the nanoparticle contract manufacturing market, North America held the largest share of 45% of the global market in 2021. The region is expected to be a highly lucrative market during the forecast period, with a high market attractiveness index. North America's dominance in the global nanoparticle contract manufacturing market can be ascribed to the increase in incidence of chronic diseases in the region. The U.S. dominated the market in North America in 2021, owing to the presence of key market players and increase in investment in R&D of nanomedicines.

Asia Pacific is projected to be the fastest-growing market for nanoparticle contract manufacturing during the forecast period. The market in the region is anticipated to grow at a high CAGR from 2022 to 2031 due to the presence of small- and medium-sized nanoparticle contract manufacturers in the region.

Analysis of Key Players in Global Nanoparticle Contract Manufacturing Market

The global nanoparticle contract manufacturing market is consolidated, with the presence of a small number of leading players. Majority of microparticle contract manufacturers are significantly investing in R&D activities to introduce advanced nanoparticle products in the market. Expansion of product portfolios and mergers & acquisitions are key strategies adopted by players to enhance their nanoparticle contract manufacturing market share.

AstraZeneca, Ascendia Pharmaceuticals, Axolabs, AVANSA Technology & Services, Ardena Holding NV, Cytodiagnostics Inc., American Elements, Encapsula NanoSciences, Fortis Life Sciences, Hongwu International Group Ltd., MyBiotech, Nanochemazone, TechNanoIndia, STA Pharmaceutical Co. Ltd., and Evonik are prominent players operating in the market.

Key Developments in Global Nanoparticle Contract Manufacturing Market

  • In September 2022, WuXi STA established a new sterile lipid nanoparticle formulation facility to enhance global CRDMO services for customers
  • In July 2022, CordenPharma, a full-service contract manufacturer, invested around US$ 10 Mn in the formulation, development, and production of new lipid nanoparticles
  • In October 2020, Fujifilm signed a contract manufacturing agreement with VLP Therapeutics for COVID-19 vaccine formulation. The self-amplifying (replicon) RNA vaccine uses a lipid nanoparticle formulation.

Key players have been profiled in the nanoparticle contract manufacturing market report based on parameters such as company overview, business strategies, product portfolio, business segments, and recent developments.

Global Nanoparticle Contract Manufacturing Market Snapshot

Attribute

Detail

Market Size Value in 2021

US$ 86.5 Bn

Market Forecast Value in 2031

More than US$ 176.5 Bn

Growth Rate

(CAGR)

7.6%

Forecast Period

2022–2031

Historical Data Available for

2017–2020

Quantitative Units

US$ Bn for Value

Market Analysis

It includes segment analysis as well as regional level analysis. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis.

Competition Landscape

  • Market share analysis by company (2021)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials

Format

Electronic (PDF) + Excel

Market Segmentation

  • Type of Nanoparticle
    • Polymer Nanoparticle
    • Lipid Nanoparticle
    • Nanocrystal
    • Inorganic Nanoparticle
  • Application
    • Therapeutics
    • Regenerative Medicines
    • Diagnostics
    • Vaccines
    • Others
  • End-user
    • Pharmaceutical Companies
    • Biotechnology Companies

Regions Covered

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Brazil
  • Mexico
  • South Africa
  • GCC Countries

Companies Profiled

  • AstraZeneca
  • Ascendia Pharmaceuticals
  • Axolabs
  • AVANSA Technology & Services
  • Ardena Holding NV
  • Cytodiagnostics Inc.
  • American Elements
  • Encapsula NanoSciences
  • Fortis Life Sciences
  • Hongwu International Group Ltd.
  • MyBiotech
  • Nanochemazone
  • TechNanoIndia
  • STA Pharmaceutical Co. Ltd.
  • Evonik

Customization Scope

Available upon request

Pricing

Available upon request

Nanoparticle Contract Manufacturing Market

Interested in this report?
Get a FREE Brochure now!

Get Free Brochure

*Get Brochure Report (PDF) sent to your email within minutes

Frequently Asked Questions

How big was the global nanoparticle contract manufacturing market in 2021?

The global nanoparticle contract manufacturing market was valued at US$ 86.5 Bn in 2021

How big will be the global nanoparticle contract manufacturing market in 2031?

The global nanoparticle contract manufacturing market is projected to reach more than US$ 176.5 Bn by 2031

What will be the CAGR of the global nanoparticle contract manufacturing market during the forecast period (2022–2031)?

The global nanoparticle contract manufacturing market is anticipated to grow at a CAGR of 7.6% from 2022 to 2031

Which are the prominent trends that affect market growth?

Increase in preference for nanoparticle contract manufacturing and rise in incidence of cancer

Which region will account for major share of the global market during the forecast period?

North America is likely to account for major share of the global nanoparticle contract manufacturing market during the forecast period

Who are the prominent players in the global nanoparticle contract manufacturing market?

AstraZeneca, Ascendia Pharmaceuticals, Axolabs, AVANSA Technology & Services, Ardena Holding NV, Cytodiagnostics Inc., American Elements, Encapsula NanoSciences, Fortis Life Sciences, Hongwu International Group Ltd., MyBiotech, Nanochemazone, TechNanoIndia, STA Pharmaceutical Co. Ltd., and Evonik

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

    2.1. Assumptions and Acronyms Used

    2.2. Research Methodology

3. Executive Summary

4. Market Overview

    4.1. Introduction

    4.2. Market Dynamics

        4.2.1. Drivers

        4.2.2. Restraints

        4.2.3. Opportunity

    4.3. Global Nanoparticle Contract Manufacturing Market Forecast

    4.4. Global Nanoparticle Contract Manufacturing Market Outlook

5. Market Outlook

    5.1. Key Industry Events (Mergers, Acquisitions, Partnerships, Collaborations, etc.)

    5.2. Key Product/Brand Analysis

    5.3. COVID-19 Pandemic Impact on Industry (Value Chain and Short/Mid/Long-term Impact)

6. Global Nanoparticle Contract Manufacturing Market Analysis and Forecast, by Type of Nanoparticle

    6.1. Introduction

    6.2. Global Nanoparticle Contract Manufacturing Market Value Share Analysis, by Type of Nanoparticle

    6.3. Global Nanoparticle Contract Manufacturing Market Forecast, by Type of Nanoparticle

        6.3.1. Polymer Nanoparticle

        6.3.2. Lipid Nanoparticle

        6.3.3. Nanocrystal

        6.3.4. Inorganic Nanoparticle

    6.4. Global Nanoparticle Contract Manufacturing Market Analysis, by Type of Nanoparticle

7. Global Nanoparticle Contract Manufacturing Market Analysis and Forecast, by Application

    7.1. Introduction

    7.2. Global Nanoparticle Contract Manufacturing Market Value Share Analysis, by Application

    7.3. Global Nanoparticle Contract Manufacturing Market Forecast, by Application

        7.3.1. Therapeutics

        7.3.2. Regenerative Medicines

        7.3.3. Diagnostics

        7.3.4. Vaccines

        7.3.5. Others

    7.4. Global Nanoparticle Contract Manufacturing Market Analysis, by Application

8. Global Nanoparticle Contract Manufacturing Market Analysis and Forecast, by End-user

    8.1. Introduction

    8.2. Global Nanoparticle Contract Manufacturing Market Value Share Analysis, by End-user

    8.3. Global Nanoparticle Contract Manufacturing Market Forecast, by End-user

        8.3.1. Pharmaceutical Companies

        8.3.2. Biotechnology Companies

    8.4. Global Nanoparticle Contract Manufacturing Market Analysis, by End-user

9. Global Nanoparticle Contract Manufacturing Market Analysis, by Region

    9.1. Global Nanoparticle Contract Manufacturing Market Analysis, by Region

    9.2. Global Nanoparticle Contract Manufacturing Market Value Share and Attractiveness Analysis, by Region

    9.3. Global Nanoparticle Contract Manufacturing Market Forecast, by Region

        9.3.1. North America

        9.3.2. Europe

        9.3.3. Asia Pacific

        9.3.4. Latin America

        9.3.5. Middle East & Africa

10. North America Nanoparticle Contract Manufacturing Market Analysis

    10.1. North America Nanoparticle Contract Manufacturing Market Overview

    10.2. North America Nanoparticle Contract Manufacturing Market Value Share and Attractiveness Analysis, by Country

    10.3. North America Nanoparticle Contract Manufacturing Market Forecast, by Country

        10.3.1. U.S.

        10.3.2. Canada

    10.4. North America Nanoparticle Contract Manufacturing Market Value Share and Attractiveness Analysis, by Type of Nanoparticle

    10.5. North America Nanoparticle Contract Manufacturing Market Forecast, by Type of Nanoparticle

        10.5.1. Polymer Nanoparticle

        10.5.2. Lipid Nanoparticle

        10.5.3. Nanocrystal

        10.5.4. Inorganic Nanoparticle

    10.6. North America Nanoparticle Contract Manufacturing Market Value Share and Attractiveness Analysis, by Application

    10.7. North America Nanoparticle Contract Manufacturing Market Forecast, by Application

        10.7.1. Therapeutics

        10.7.2. Regenerative Medicines

        10.7.3. Diagnostics

        10.7.4. Vaccines

        10.7.5. Others

    10.8. North America Nanoparticle Contract Manufacturing Market Value Share and Attractiveness Analysis, by End-user

    10.9. North America Nanoparticle Contract Manufacturing Market Forecast, by End-user

        10.9.1. Pharmaceutical Companies

        10.9.2. Biotechnology Companies

11. Europe Nanoparticle Contract Manufacturing Market Analysis

    11.1. Europe Nanoparticle Contract Manufacturing Market Overview

    11.2. Europe Nanoparticle Contract Manufacturing Market Value Share and Attractiveness Analysis, by Country

    11.3. Europe Nanoparticle Contract Manufacturing Market Forecast, by Country/Sub-region

        11.3.1. Germany

        11.3.2. U.K.

        11.3.3. France

        11.3.4. Italy

        11.3.5. Spain

        11.3.6. Rest of Europe

    11.4. Europe Nanoparticle Contract Manufacturing Market Value Share and Attractiveness Analysis, by Type of Nanoparticle

    11.5. Europe Nanoparticle Contract Manufacturing Market Forecast, by Type of Nanoparticle

        11.5.1. Polymer Nanoparticle

        11.5.2. Lipid Nanoparticle

        11.5.3. Nanocrystal

        11.5.4. Inorganic Nanoparticle

    11.6. Europe Nanoparticle Contract Manufacturing Market Value Share and Attractiveness Analysis, by Application

    11.7. Europe Nanoparticle Contract Manufacturing Market Forecast, by Application

        11.7.1. Therapeutics

        11.7.2. Regenerative Medicines

        11.7.3. Diagnostics

        11.7.4. Vaccines

        11.7.5. Others

    11.8. Europe Nanoparticle Contract Manufacturing Market Value Share and Attractiveness Analysis, by End-user

    11.9. Europe Nanoparticle Contract Manufacturing Market Forecast, by End-user

        11.9.1. Pharmaceutical Companies

        11.9.2. Biotechnology Companies

12. Asia Pacific Nanoparticle Contract Manufacturing Market Analysis

    12.1. Asia Pacific Nanoparticle Contract Manufacturing Market Overview

    12.2. Asia Pacific Nanoparticle Contract Manufacturing Market Value Share and Attractiveness Analysis, by Country

    12.3. Asia Pacific Nanoparticle Contract Manufacturing Market Forecast, by Country/Sub-region

        12.3.1. China

        12.3.2. India

        12.3.3. Japan

        12.3.4. Australia & New Zealand

        12.3.5. Rest of Asia Pacific

    12.4. Asia Pacific Nanoparticle Contract Manufacturing Market Value Share and Attractiveness Analysis, by Type of Nanoparticle

    12.5. Asia Pacific Nanoparticle Contract Manufacturing Market Forecast, by Type of Nanoparticle

        12.5.1. Polymer Nanoparticle

        12.5.2. Lipid Nanoparticle

        12.5.3. Nanocrystal

        12.5.4. Inorganic Nanoparticle

    12.6. Asia Pacific Nanoparticle Contract Manufacturing Market Value Share and Attractiveness Analysis, by Application

    12.7. Asia Pacific Nanoparticle Contract Manufacturing Market Forecast, by Application

        12.7.1. Therapeutics

        12.7.2. Regenerative Medicines

        12.7.3. Diagnostics

        12.7.4. Vaccines

        12.7.5. Others

    12.8. Asia Pacific Nanoparticle Contract Manufacturing Market Value Share and Attractiveness Analysis, by End-user

    12.9. Asia Pacific Nanoparticle Contract Manufacturing Market Forecast, by End-user

        12.9.1. Pharmaceutical Companies

        12.9.2. Biotechnology Companies

13. Latin America Nanoparticle Contract Manufacturing Market Analysis

    13.1. Latin America Nanoparticle Contract Manufacturing Market Overview

    13.2. Latin America Nanoparticle Contract Manufacturing Market Value Share and Attractiveness Analysis, by Country

    13.3. Latin America Nanoparticle Contract Manufacturing Market Forecast, by Country/Sub-region

        13.3.1. Brazil

        13.3.2. Mexico

        13.3.3. Rest of Latin America

    13.4. Latin America Nanoparticle Contract Manufacturing Market Value Share and Attractiveness Analysis, by Type of Nanoparticle

    13.5. Latin America Nanoparticle Contract Manufacturing Market Forecast, by Type of Nanoparticle

        13.5.1. Polymer Nanoparticle

        13.5.2. Lipid Nanoparticle

        13.5.3. Nanocrystal

        13.5.4. Inorganic Nanoparticle

    13.6. Latin America Nanoparticle Contract Manufacturing Market Value Share and Attractiveness Analysis, by Application

    13.7. Latin America Nanoparticle Contract Manufacturing Market Forecast, by Application

        13.7.1. Therapeutics

        13.7.2. Regenerative Medicines

        13.7.3. Diagnostics

        13.7.4. Vaccines

        13.7.5. Others

    13.8. Latin America Nanoparticle Contract Manufacturing Market Value Share and Attractiveness Analysis, by End-user

    13.9. Latin America Nanoparticle Contract Manufacturing Market Forecast, by End-user

    13.10. Pharmaceutical Companies

    13.11. Biotechnology Companies

14. Middle East & Africa Nanoparticle Contract Manufacturing Market Analysis

    14.1. Middle East & Africa Nanoparticle Contract Manufacturing Market Overview

    14.2. Middle East & Africa Nanoparticle Contract Manufacturing Market Value Share and Attractiveness Analysis, by Country

    14.3. Middle East & Africa Nanoparticle Contract Manufacturing Market Forecast, by Country/Sub-region

        14.3.1. GCC Countries

        14.3.2. South Africa

        14.3.3. Rest of Middle East & Africa

    14.4. Middle East & Africa Nanoparticle Contract Manufacturing Market Value Share and Attractiveness Analysis, by Type of Nanoparticle

    14.5. Middle East & Africa Nanoparticle Contract Manufacturing Market Forecast, by Type of Nanoparticle

        14.5.1. Polymer Nanoparticle

        14.5.2. Lipid Nanoparticle

        14.5.3. Nanocrystal

        14.5.4. Inorganic Nanoparticle

    14.6. Middle East & Africa Nanoparticle Contract Manufacturing Market Value Share and Attractiveness Analysis, by Application

    14.7. Middle East & Africa Nanoparticle Contract Manufacturing Market Forecast, by Application

        14.7.1. Therapeutics

        14.7.2. Regenerative Medicines

        14.7.3. Diagnostics

        14.7.4. Vaccines

        14.7.5. Others

    14.8. Middle East & Africa Nanoparticle Contract Manufacturing Market Value Share and Attractiveness Analysis, by End-user

    14.9. Middle East & Africa Nanoparticle Contract Manufacturing Market Forecast, by End-user

        14.9.1. Pharmaceutical Companies

        14.9.2. Biotechnology Companies

15. Competition Landscape

    15.1. Market Player - Competition Matrix (by Tier and Size of Companies)

    15.2. Company Profiles

        15.2.1. AstraZeneca

            15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.1.2. Product Portfolio

            15.2.1.3. Financial Overview

            15.2.1.4. Strategic Overview

            15.2.1.5. SWOT Analysis

        15.2.2. Ascendia Pharmaceuticals

            15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.2.2. Product Portfolio

            15.2.2.3. Strategic Overview

            15.2.2.4. SWOT Analysis

        15.2.3. Axolabs

            15.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.3.2. Product Portfolio

            15.2.3.3. Strategic Overview

            15.2.3.4. SWOT Analysis

        15.2.4. AVANSA Technology & Services

            15.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.4.2. Product Portfolio

            15.2.4.3. Strategic Overview

            15.2.4.4. SWOT Analysis

        15.2.5. Ardena Holding NV

            15.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.5.2. Product Portfolio

            15.2.5.3. Strategic Overview

            15.2.5.4. SWOT Analysis

        15.2.6. Cytodiagnostics Inc.

            15.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.6.2. Product Portfolio

            15.2.6.3. Strategic Overview

            15.2.6.4. SWOT Analysis

        15.2.7. American Elements

            15.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.7.2. Product Portfolio

            15.2.7.3. Strategic Overview

            15.2.7.4. SWOT Analysis

        15.2.8. Encapsula NanoSciences

            15.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.8.2. Product Portfolio

            15.2.8.3. Strategic Overview

            15.2.8.4. SWOT Analysis

        15.2.9. Fortis Life Sciences

            15.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.9.2. Product Portfolio

            15.2.9.3. Strategic Overview

            15.2.9.4. SWOT Analysis

        15.2.10. Hongwu International Group Ltd.

            15.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.10.2. Product Portfolio

            15.2.10.3. Strategic Overview

            15.2.10.4. SWOT Analysis

        15.2.11. MyBiotech

            15.2.11.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.11.2. Product Portfolio

            15.2.11.3. Strategic Overview

            15.2.11.4. SWOT Analysis

        15.2.12. Nanochemazone

            15.2.12.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.12.2. Product Portfolio

            15.2.12.3. Strategic Overview

            15.2.12.4. SWOT Analysis

        15.2.13. TechNanoIndia

            15.2.13.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.13.2. Product Portfolio

            15.2.13.3. Strategic Overview

            15.2.13.4. SWOT Analysis

        15.2.14. STA Pharmaceutical Co. Ltd.

            15.2.14.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.14.2. Product Portfolio

            15.2.14.3. Strategic Overview

            15.2.14.4. SWOT Analysis

        15.2.15. Evonik

            15.2.15.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.15.2. Product Portfolio

            15.2.15.3. Strategic Overview

            15.2.15.4. SWOT Analysis

List of Tables

Table 01: Global Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast, by Type of Nanoparticle, 2017–2031

Table 02: Global Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 03: Global Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 04: Global Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast, by Region, 2017–2031

Table 05: North America Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast, by Country, 2017–2031

Table 06: North America Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast, by Type of Nanoparticle, 2017–2031

Table 07: North America Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 08: North America Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 09: Europe Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 10: Europe Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast, by Type of Nanoparticle, 2017–2031

Table 11: Europe Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 12: Europe Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 12: Asia Pacific Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 14: Asia Pacific Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast, by Type of Nanoparticle, 2017–2031

Table 15: Asia Pacific Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 16: Asia Pacific Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 17: Latin America Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 18: Latin America Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast, by Type of Nanoparticle, 2017–2031

Table 19: Latin America Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 20: Latin America Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 21: Middle East & Africa Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 22: Middle East & Africa Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast, by Type of Nanoparticle, 2017–2031

Table 23: Middle East & Africa Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 24: Middle East & Africa Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 25: AstraZeneca Business Overview

Table 26: Ascendia Pharmaceuticals Business Overview

Table 27: Axolabs Overview

Table 28: AVANSA Technology & Services Business Overview

Table 29: Ardena Holding NV Business Overview

Table 30: Cytodiagnostics Inc. Business Overview

Table 31: American Elements Business Overview

Table 32: Encapsula NanoSciences Business Overview

Table 33: Fortis Life Sciences Business Overview

Table 34: Hongwu International Group Ltd Business Overview

Table 35: MyBiotech Business Overview

Table 36: Nanochemazone Business Overview

Table 37: TechNanoIndia Business Overview

Table 38: STA Pharmaceutical Co. Ltd. Business Overview

Table 39: Evonik Business Overview

List of Figures

Figure 01: Market Share, by Type of Nanoparticle

Figure 02: Market Share, by Application

Figure 03: Market Share, by Region

Figure 04: Global Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast, 2017–2031

Figure 05: Global Nanoparticle Contract Manufacturing Market Value Share, by Type of Nanoparticle, 2021

Figure 06: Global Nanoparticle Contract Manufacturing Market Value Share, by End-user, 2021

Figure 07: Global Nanoparticle Contract Manufacturing Market Value Share, by Application, 2021

Figure 08: Global Nanoparticle Contract Manufacturing Market Value Share, by Region, 2021

Figure 09: Global Nanoparticle Contract Manufacturing Market Value Share Analysis, by Type of Nanoparticle, 2021 and 2031

Figure 10: Global Nanoparticle Contract Manufacturing Market Attractiveness, by Type of Nanoparticle, 2022–2031

Figure 11: Global Nanoparticle Contract Manufacturing Market Revenue (US$ Mn), by Polymer Nanoparticle, 2017–2031

Figure 12: Global Nanoparticle Contract Manufacturing Market Revenue (US$ Mn), by Lipid Nanoparticle, 2017–2031

Figure 13: Global Nanoparticle Contract Manufacturing Market Revenue (US$ Mn), by Nanocrystal, 2017–2031

Figure 14: Global Nanoparticle Contract Manufacturing Market Revenue (US$ Mn), by Inorganic Nanoparticle, 2017–2031

Figure 15: Global Nanoparticle Contract Manufacturing Market Value Share Analysis, by Application, 2021 and 2031

Figure 16: Global Nanoparticle Contract Manufacturing Market Attractiveness, by Application, 2022–2031

Figure 17: Global Nanoparticle Contract Manufacturing Market Revenue (US$ Mn), by Therapeutics, 2017–2031

Figure 18: Global Nanoparticle Contract Manufacturing Market Revenue (US$ Mn), by Regenerative Medicines, 2017–2031

Figure 19: Global Nanoparticle Contract Manufacturing Market Revenue (US$ Mn), by Diagnostics, 2017–2031

Figure 20: Global Nanoparticle Contract Manufacturing Market Revenue (US$ Mn), by Vaccines, 2017–2031

Figure 21: Global Nanoparticle Contract Manufacturing Market Revenue (US$ Mn), by Others, 2017–2031

Figure 22: Global Nanoparticle Contract Manufacturing Market Value Share Analysis, by End-user, 2021 and 2031

Figure 23: Global Nanoparticle Contract Manufacturing Market Attractiveness, by End-user, 2022–2031

Figure 24: Global Nanoparticle Contract Manufacturing Market Revenue (US$ Mn), by Pharmaceutical Companies, 2017–2031

Figure 25: Global Nanoparticle Contract Manufacturing Market Revenue (US$ Mn), by Biotechnology Companies, 2017–2031

Figure 26: Global Nanoparticle Contract Manufacturing Market Value Share Analysis, by Region, 2021 and 2031

Figure 27: Global Nanoparticle Contract Manufacturing Market Attractiveness, by Region, 2022-2031

Figure 28: North America Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 29: North America Nanoparticle Contract Manufacturing Market Value Share (%), by Country, 2021 and 2031

Figure 30: North America Nanoparticle Contract Manufacturing Market Attractiveness, by Country, 2022–2031

Figure 31: North America Nanoparticle Contract Manufacturing Market Value Share Analysis, by Type of Nanoparticle, 2021 and 2031

Figure 32: North America Nanoparticle Contract Manufacturing Market Attractiveness, by Type of Nanoparticle, 2022–2031

Figure 33: North America Nanoparticle Contract Manufacturing Market Value Share Analysis, by Application, 2021 and 2031

Figure 34: North America Nanoparticle Contract Manufacturing Market Attractiveness, by Application, 2022–2031

Figure 35: North America Nanoparticle Contract Manufacturing Market Value Share Analysis, by End-user, 2021 and 2031

Figure 36: North America Nanoparticle Contract Manufacturing Market Attractiveness, by End-user, 2022–2031

Figure 37: Europe Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 38: Europe Nanoparticle Contract Manufacturing Market Value Share (%), by Country/Sub-region, 2021 and 2031

Figure 39: Europe Nanoparticle Contract Manufacturing Market Attractiveness, by Country/Sub-region, 2022–2031

Figure 40: Europe Nanoparticle Contract Manufacturing Market Value Share Analysis, by Type of Nanoparticle, 2021 and 2031

Figure 41: Europe Nanoparticle Contract Manufacturing Market Attractiveness, by Type of Nanoparticle, 2022–2031

Figure 42: Europe Nanoparticle Contract Manufacturing Market Value Share Analysis, by Application, 2021 and 2031

Figure 43: Europe Nanoparticle Contract Manufacturing Market Attractiveness, by Application, 2022–2031

Figure 44: Europe Nanoparticle Contract Manufacturing Market Value Share Analysis, by End-user, 2021 and 2031

Figure 45: Europe Nanoparticle Contract Manufacturing Market Attractiveness, by End-user, 2022–2031

Figure 46: Asia Pacific Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 47: Asia Pacific Nanoparticle Contract Manufacturing Market Value Share (%), by Country/Sub-region, 2021 and 2031

Figure 48: Asia Pacific Nanoparticle Contract Manufacturing Market Attractiveness, by Country/Sub-region, 2022–2031

Figure 49: Asia Pacific Nanoparticle Contract Manufacturing Market Value Share Analysis, by Type of Nanoparticle, 2021 and 2031

Figure 50: Asia Pacific Nanoparticle Contract Manufacturing Market Attractiveness, by Type of Nanoparticle, 2022–2031

Figure 51: Asia Pacific Nanoparticle Contract Manufacturing Market Value Share Analysis, by Application, 2021 and 2031

Figure 52: Asia Pacific Nanoparticle Contract Manufacturing Market Attractiveness, by Application, 2022–2031

Figure 53: Asia Pacific Nanoparticle Contract Manufacturing Market Value Share Analysis, by End-user, 2021 and 2031

Figure 54: Asia Pacific Nanoparticle Contract Manufacturing Market Attractiveness, by End-user, 2022–2031

Figure 55: Latin America Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 56: Latin America Nanoparticle Contract Manufacturing Market Value Share (%), by Country/Sub-region, 2021 and 2031 

Figure 57: Latin America Nanoparticle Contract Manufacturing Market Attractiveness, by Country/Sub-region, 2022–2031

Figure 58: Latin America Nanoparticle Contract Manufacturing Market Value Share Analysis, by Type of Nanoparticle, 2021 and 2031 

Figure 59: Latin America Nanoparticle Contract Manufacturing Market Attractiveness, by Type of Nanoparticle, 2022–2031

Figure 60: Latin America Nanoparticle Contract Manufacturing Market Value Share Analysis, by Application, 2021 and 2031

Figure 61: Latin America Nanoparticle Contract Manufacturing Market Attractiveness, by Application, 2022–2031

Figure 62: Latin America Nanoparticle Contract Manufacturing Market Value Share Analysis, by End-user, 2021 and 2031

Figure 63: Latin America Nanoparticle Contract Manufacturing Market Attractiveness, by End-user, 2022–2031

Figure 64: Middle East & Africa Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 65: Middle East & Africa Nanoparticle Contract Manufacturing Market Value Share (%), by Country/Sub-region, 2021 and 2031

Figure 66: Middle East & Africa Nanoparticle Contract Manufacturing Market Attractiveness, by Country/Sub-region, 2022–2031

Figure 67: Middle East & Africa Nanoparticle Contract Manufacturing Market Value Share Analysis, by Type of Nanoparticle, 2021 and 2031

Figure 68: Middle East & Africa Nanoparticle Contract Manufacturing Market Attractiveness, by Type of Nanoparticle, 2022–2031

Figure 69: Middle East & Africa Nanoparticle Contract Manufacturing Market Value Share Analysis, by Application, 2021 and 2031

Figure 70: Middle East & Africa Nanoparticle Contract Manufacturing Market Attractiveness, by Application, 2022–2031

Figure 71: Middle East & Africa Nanoparticle Contract Manufacturing Market Value Share Analysis, by End-user, 2021 and 2031

Figure 72: Middle East & Africa Nanoparticle Contract Manufacturing Market Attractiveness, by End-user, 2022–2031

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

976

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved